Skip to content
Preprint · CC0 via OpenAlex

Enhancing bone marrow-derived mesenchymal stem cell therapeutic potential through mTOR inhibition

Lisa Stukenborg, Christian Sell

iDEA - Drexel University Institutional Repository · 2022

Abstract

Despite our best efforts to avoid growing older, aging is an inevitable phenomenon that affects all living organisms. The aging process results from normal biological processes that are necessary for maintaining cellular homeostasis, including protein translation and regulation, lipid and nucleotide biosynthesis, nuclear maintenance and chromatin modifications. Over time, cells begin to accumulate damage, enter a unique state known as senescence(definition), disrupting their functionality and thereby contributing to a reduction in organismal lifespan. One of the hallmarks of senescence is an irreversible arrest of the cell cycle resulting in cells which are no longer able to proliferate. Since its discovery, senescence in somatic cells has been well defined, but there are still limitations of our knowledge regarding senescence in stem cells, however, a progressive decline in adult stem cell function is a feature of aged tissues and contributes to multiple age-related diseases. Of particular interest are bone marrow mesenchymal stem cells, also known as bone marrow stromal cells (BMSCs), which are multipotent and have significant therapeutic potential. In this study, we aimed to understand senescence in human bone-marrow mesenchymal stem cells. In addition, we examined the impact of inhibiting the mechanistic/mammalian target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) (mTOR), using rapamycin, on senescence in BMSCs. We found that stem cells undergo senescence similarly to somatic cells, but also have unique features that have not yet been reported. Due to the implications of senescence in various diseases, this research helps shed light on the role of stem cells during organismal aging.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.17918/00001098
Canonical
link ↗
Fetched
2026-11-10 MST

Cite this

APA
Stukenborg, L., &amp; Sell, C. (2022). Enhancing bone marrow-derived mesenchymal stem cell therapeutic potential through mTOR inhibition. <em>iDEA - Drexel University Institutional Repository</em>. https://doi.org/10.17918/00001098
Vancouver
Stukenborg L, Sell C. Enhancing bone marrow-derived mesenchymal stem cell therapeutic potential through mTOR inhibition. iDEA - Drexel University Institutional Repository. 2022. doi:10.17918/00001098.
BibTeX
@unpublished{lisa2022Enhanc, title = {Enhancing bone marrow-derived mesenchymal stem cell therapeutic potential through mTOR inhibition}, author = {Lisa Stukenborg and Christian Sell}, journal = {iDEA - Drexel University Institutional Repository}, year = {2022}, doi = {10.17918/00001098}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings